Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.88 EUR | +4.19% | +6.30% | -21.65% |
May. 08 | Terhi Kauppi Resigns as Chief Financial Officer of Remedy Entertainment Plc, Effective June 30, 2024 | CI |
Apr. 29 | Transcript : Remedy Entertainment Oyj, Q1 2024 Earnings Call, Apr 29, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- With an enterprise value anticipated at 5.13 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.65% | 281M | - | ||
+11.75% | 3,123B | C+ | ||
+10.06% | 86.45B | B | ||
+6.04% | 78.6B | B+ | ||
-14.55% | 53.99B | B+ | ||
+26.73% | 48.46B | D+ | ||
-24.44% | 46.78B | B- | ||
+31.74% | 46.36B | D+ | ||
+82.12% | 42.36B | D+ | ||
-8.15% | 25.25B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- REMEDY Stock
- Ratings Remedy Entertainment Oyj